-
Latest News
Archives
Tag Archives: rituximab
The RituxME & CycloME studies – video of Dr Oystein Fluge talk
Video posted on the RME Sverige You Tube channel, 19 Nov 2016: The RituxME and CycloME studies – Ongoing Clinical Research in the ME/CFS Research Group, by Öystein Fluge, MD, Dep. Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norge … Continue reading
Posted in News
Tagged Cyclophosphamide, Dr Oystein Fluge, rituximab, RME Sverige, video
Comments Off on The RituxME & CycloME studies – video of Dr Oystein Fluge talk
New rituximab trial results from Norway
Research abstract: Myalgic Encephalopathy/Chronic Fatigue Syndrome (ME/CFS) is a disease of unknown etiology. We have previously suggested clinical benefit from B-cell depletion using the monoclonal anti-CD20 antibody rituximab in a randomized and placebo-controlled study. Prolonged responses were then demonstrated in … Continue reading
Posted in News
Tagged B-cell, Dr Oystein Fluge, Norway, Prof Olav Mella, rituximab, T-cell
Comments Off on New rituximab trial results from Norway
Unexpected findings & promoting monocausal claims, a cautionary tale
Article abstract: Stories of serendipitous discoveries in medicine incorrectly imply that the path from an unexpected observation to major discovery is straightforward or guaranteed. In this paper, I examine a case from the field of research about chronic fatigue syndrome (CFS). In Norway, … Continue reading
Posted in News
Tagged causal complexity, evidence based medicine, monocausal, Norway, rituximab
Comments Off on Unexpected findings & promoting monocausal claims, a cautionary tale
IIMEC 2016 conference report by Dr R Vallings
IIME 11 conference report by Dr Rosamund Vallings MB BS On 3rd June, 2016, I was privileged to attend the 11th Invest in ME – Research International conference in London – the theme being “A New Decade of Invest in ME … Continue reading
Posted in News
Tagged auto-antibodies, biomarkers, conference, Dr Rosamund Vallings, gut virome, IiME, Invest in ME, microbiota, Receptors, rituximab, sleep
Comments Off on IIMEC 2016 conference report by Dr R Vallings
People with ME/CFS have long been told it’s all in their head – these scientists disagree
The Canary blog, 8 June 2016, by Conrad Bower: CFS have long been told it’s all in their head – these scientists disagree A conference bringing together the brightest minds in Myalgic Encephalomyelitis a.k.a Chronic Fatigue Syndrome (ME/CFS) research, presented … Continue reading
Posted in News
Tagged biomedical research, Dr Ian Gibson, gut microbiome, Invest in ME, rituximab, Severely Ill-BIG DATA Study, The Canary
Comments Off on People with ME/CFS have long been told it’s all in their head – these scientists disagree
ME and rituximab in Notodden Norway
ME-foreldrene blog: Lecture by Hanne Thürmer, Notodden. RituxME and current development, 13 April 2016 Lecture by dr Hanne Thürmer, Notodden Hospital Original in Norwegian/Norsk original From a lecture given at the local department of the Norwegian ME-association in Notodden, avd … Continue reading
Posted in News
Tagged Dr Hanne Thurmer, Norway, Notodden, rituximab
Comments Off on ME and rituximab in Notodden Norway
Video interview with parent Mary Dimmock about her son and rituximab
Episode 78 of Llewellyn King’s ME/CFS Alert videos interviews Mary Dimmock, whose son has ME and who is receiving RITUXAN (rituximab) treatment privately. (24 mins)
Posted in News
Tagged Llewellyn King, Mary Dimmock, ME/CFS Alert, rituxan, rituximab, video
Comments Off on Video interview with parent Mary Dimmock about her son and rituximab
CFS & Rituximab revisited
Science based medicine article: Chronic Fatigue Syndrome: Rituximab Revisited by Harriet Hall (the SkepDoc), January 19, 2016 Three years ago I wrote about an experimental treatment for chronic fatigue syndrome (CFS): rituximab (brand name Rituxan). I was concerned that doctors who … Continue reading
IiME rituximab research update
Invest in ME press release: Invest in ME (Research) has created a separate strand to our Biomedical Research Fund which will be explicitly used for this UK rituximab trial. A specific fund-raising thermometer was created just for this project – see … Continue reading